Mahesh Kate
Overview
Explore the profile of Mahesh Kate including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
478
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chaggar G, Pahwa A, Buck B, Jeerakathil T, Shuaib A, Almekhlafi M, et al.
Can J Neurol Sci
. 2024 Dec;
:1-6.
PMID: 39641463
Background: The Edmonton-based mobile stroke unit (MSU), which transports patients to the University of Alberta Hospital (UAH), enrolled patients in the Intravenous Tenecteplase Compared with Alteplase for Acute Ischemic Stroke...
2.
Sarmiento R, Wagner A, Sheriff A, Taralson C, Moniz N, Opsahl J, et al.
NeuroSci
. 2024 Nov;
5(3):291-300.
PMID: 39483280
The burden of simultaneous acute code stroke activation (ACSA) is not known. We aim to assess the effect of simultaneous ACSA on workflow metrics and home time at 90 days...
3.
Mccombe J, Smyth P, Kate M, So H, Vu K, Luu H, et al.
Can J Neurol Sci
. 2024 Oct;
:1-12.
PMID: 39356041
Background: We aimed to (1) report updated estimates of direct healthcare costs for people living with MS (pwMS), (2) contrast costs to a control population and (3) explore differences between...
4.
Akhtar N, Kate M, Kamran S, Joseph S, Morgan D, Uy R, et al.
Front Neurol
. 2024 May;
15:1384985.
PMID: 38756212
Objectives: Functional outcomes in patients with intracerebral hemorrhage (ICH) have not been well characterized in the Middle East and North Africa Region. We report the 30 and 90-day clinical outcomes...
5.
Balcom E, Mccombe J, Kate M, Vu K, Martins K, Aponte-Hao S, et al.
Can J Neurol Sci
. 2024 Apr;
:1-9.
PMID: 38600770
Background: Understanding disease-modifying therapy (DMT) use and healthcare resource utilization by different geographical areas among people living with multiple sclerosis (pwMS) may identify care gaps that can be used to...
6.
Balcom E, Smyth P, Kate M, Vu K, Martins K, Aponte-Hao S, et al.
J Neurol Sci
. 2024 Feb;
458:122913.
PMID: 38335712
Background: Estimating multiple sclerosis (MS) prevalence and incidence, and assessing the utilisation of disease-modifying therapies (DMTs) and healthcare resources over time is critical to understanding the evolution of disease burden...
7.
Nair R, Singh N, Kate M, Asdaghi N, Sarmiento R, Bala F, et al.
Stroke Vasc Neurol
. 2024 Jan;
9(6):604-612.
PMID: 38296590
Background: In ischaemic stroke, minor deficits (National Institutes of Health Stroke Scale (NIHSS) ≤5) at presentation are common but often progress, leaving patients with significant disability. We compared the efficacy...
8.
Zhou M, Stobbe R, Szczepankiewicz F, Budde M, Buck B, Kate M, et al.
Magn Reson Med
. 2023 Dec;
91(5):2126-2141.
PMID: 38156813
Purpose: Tensor-valued diffusion encoding can disentangle orientation dispersion and subvoxel anisotropy, potentially offering insight into microstructural changes after cerebral ischemia. The purpose was to evaluate tensor-valued diffusion MRI in human...
9.
Nair R, Sarmiento R, Sheriff A, Shuaib A, Buck B, Gauthier M, et al.
PLoS One
. 2023 May;
18(5):e0284879.
PMID: 37141237
Background: Remote ischemic conditioning (RIC) is delivered by a blood pressure cuff over the limb, raising pressure 50 mmHg above the systolic blood pressure, to a maximum of 200 mmHg....
10.
Alrohimi A, Rose D, Burgin W, Renati S, Hilker N, Deng W, et al.
Int J Stroke
. 2023 Mar;
18(7):864-872.
PMID: 36907985
Introduction: Precise risk of hemorrhagic transformation (HT) in acute ischemic stroke (AIS) remains unknown, leading to delays in anticoagulation initiation for secondary stroke prevention. We sought to assess the rate...